These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 32634856

  • 1. A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiency.
    Westbury SK, Whyte CS, Stephens J, Downes K, Turro E, Claesen K, Mertens JC, Hendriks D, Latif AL, Leishman EJ, NIHR BioResourceNIHR BioResource, Cambridge University Hospitals, Cambridge, UK., Mutch NJ, Tait RC, Mumford AD.
    J Thromb Haemost; 2020 Sep; 18(9):2209-2214. PubMed ID: 32634856
    [Abstract] [Full Text] [Related]

  • 2. Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy.
    Burley K, Whyte CS, Westbury SK, Walker M, Stirrups KE, Turro E, NIHR BioResource, Chapman OG, Reilly-Stitt C, Mutch NJ, Mumford AD.
    Blood; 2016 Oct 06; 128(14):1879-1883. PubMed ID: 27436851
    [Abstract] [Full Text] [Related]

  • 3. Identification of a thrombomodulin interaction site on thrombin-activatable fibrinolysis inhibitor that mediates accelerated activation by thrombin.
    Marar TT, Boffa MB.
    J Thromb Haemost; 2016 Apr 06; 14(4):772-83. PubMed ID: 26816270
    [Abstract] [Full Text] [Related]

  • 4. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow.
    van Moorsel MVA, Poolen GC, Koekman CA, Verhoef S, de Maat S, Barendrecht A, van Kleef ND, Meijers JCM, Schiffelers RM, Maas C, Urbanus RT.
    J Thromb Haemost; 2022 May 06; 20(5):1213-1222. PubMed ID: 35170225
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of a novel thrombomodulin c.1487delC,p.(Pro496Argfs*10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype.
    Morrow GB, Beavis J, Harper S, Bignell P, Laffan MA, Curry N.
    Thromb Res; 2021 Jan 06; 197():100-108. PubMed ID: 33190022
    [Abstract] [Full Text] [Related]

  • 6. Lys 42/43/44 and Arg 12 of thrombin-activable fibrinolysis inhibitor comprise a thrombomodulin exosite essential for its antifibrinolytic potential.
    Wu C, Stafford AR, Fredenburgh JC, Weitz JI, Gils A, Declerck PJ, Kim PY.
    Thromb Haemost; 2017 Jul 26; 117(8):1509-1517. PubMed ID: 28640323
    [Abstract] [Full Text] [Related]

  • 7. The profibrinolytic effect of plasma thrombomodulin in factor XI deficiency and its implications in hemostasis.
    Dai L, Mitchell M, Savidge G, Alhaq A.
    J Thromb Haemost; 2004 Dec 26; 2(12):2200-4. PubMed ID: 15613027
    [Abstract] [Full Text] [Related]

  • 8. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO.
    J Biol Chem; 2011 Jan 07; 286(1):502-10. PubMed ID: 21041299
    [Abstract] [Full Text] [Related]

  • 9. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L, Nesheim M, Morser J, Tracy PB.
    J Biol Chem; 1998 Jan 30; 273(5):2792-8. PubMed ID: 9446587
    [Abstract] [Full Text] [Related]

  • 10. Visualization of Domain- and Concentration-Dependent Impact of Thrombomodulin on Differential Regulation of Coagulation and Fibrinolysis.
    Mochizuki L, Sano H, Honkura N, Masumoto K, Urano T, Suzuki Y.
    Thromb Haemost; 2023 Jan 30; 123(1):16-26. PubMed ID: 36307100
    [Abstract] [Full Text] [Related]

  • 11. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
    Binette TM, Taylor FB, Peer G, Bajzar L.
    Blood; 2007 Nov 01; 110(9):3168-75. PubMed ID: 17644733
    [Abstract] [Full Text] [Related]

  • 12. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ.
    J Thromb Haemost; 2016 Aug 01; 14(8):1629-38. PubMed ID: 27279497
    [Abstract] [Full Text] [Related]

  • 13. Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.
    Leenaerts D, Aernouts J, Van Der Veken P, Sim Y, Lambeir AM, Hendriks D.
    Thromb Haemost; 2017 Jul 26; 117(8):1498-1508. PubMed ID: 28692110
    [Abstract] [Full Text] [Related]

  • 14. A role for arginine-12 in thrombin-thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor.
    Plug T, Kramer G, Meijers JC.
    J Thromb Haemost; 2014 Oct 26; 12(10):1717-25. PubMed ID: 25066897
    [Abstract] [Full Text] [Related]

  • 15. Thrombomodulin suppresses invasiveness of HT1080 tumor cells by reducing plasminogen activation on the cell surface through activation of thrombin-activatable fibrinolysis inhibitor.
    Higuchi T, Nakamura T, Kakutani H, Ishii H.
    Biol Pharm Bull; 2009 Feb 26; 32(2):179-85. PubMed ID: 19182372
    [Abstract] [Full Text] [Related]

  • 16. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L, Wu C, Dwivedi DJ, Wu C, Kim PY, Liaw PC.
    Thromb Res; 2017 Apr 26; 152():30-37. PubMed ID: 28219843
    [Abstract] [Full Text] [Related]

  • 17. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.
    J Thromb Haemost; 2016 Aug 26; 14(8):1603-14. PubMed ID: 27094709
    [Abstract] [Full Text] [Related]

  • 18. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
    Mosnier LO, Elisen MG, Bouma BN, Meijers JC.
    Thromb Haemost; 2001 Oct 26; 86(4):1057-64. PubMed ID: 11686324
    [Abstract] [Full Text] [Related]

  • 19. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T.
    Nihon Yakurigaku Zasshi; 2000 Nov 26; 116(5):298-303. PubMed ID: 11215380
    [Abstract] [Full Text] [Related]

  • 20. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
    Mohamed HT, El-Husseiny N, El-Ghonaimy EA, Ibrahim SA, Bazzi ZA, Cavallo-Medved D, Boffa MB, El-Shinawi M, Mohamed MM.
    Curr Probl Cancer; 2018 Nov 26; 42(2):215-230. PubMed ID: 29459177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.